세계의 컴패니언 진단 시장 예측 2022-2030년

출판:Inkwood Research(잉크우드 리서치) 출판년월:2022년08월

GLOBAL COMPANION DIAGNOSTICS MARKET FORECAST 2022-2030

기술(현장혼성화, 중합효소연쇄반응, 면역조직화학, 차세대 염기서열분석, 기타 기술) 시장 적응증(종양학, 신경학, 전염병, 기타 적응증) 최종 사용자별 시장(제약 및 바이오제약 회사, 참조 연구소, 기타 최종 사용자) 지역별 제품 및 서비스별 시장(분석 키트 및 시약, 소프트웨어 및 서비스)

페이지수 205
가격
싱글 사용자 라이센스 USD 2,500
다중 사용자 라이센스 USD 3,000
엔터프라이즈 라이센스 USD 4,500
구성 영문조사보고서

리포트목차    주문/문의    납기/라이센스안내

Sample Request

Global Companion Diagnostics Market by Technology (in Situ Hybridization, Polymerase Chain Reaction, Immunohistochemistry, Next Generation Sequencing, Other Technologies) Market by Indication (Oncology, Neurology, Infectious Diseases, Other Indications) Market by End-user (Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories, Other End-users) Market by Products & Services (Assay Kits and Reagents, Software & Services) by Geography

KEY FINDINGS
The global companion diagnostics market is forecasted to register a CAGR of 13.29% over the estimated years 2022 to 2030. The market’s growth is accredited to the rising number of cancer cases and mortalities, the increasing number of adverse drug reaction cases, and the growing popularity of precision medicines.
글로벌 컴패니언 진단 시장은 2022년에서 2030년 사이에 13.29%의 CAGR을 기록할 것으로 예상됩니다.
이 시장의 성장은 암 사례 및 사망률의 증가, 약물 부작용 사례의 증가, 정밀 의약품의 인기 증가에 기인합니다.

GLOBAL COMPANION DIAGNOSTICS MARKET Inkwood Research

MARKET INSIGHTS
Companion diagnostics provide crucial data for patient classification, facilitating the effective and secure usage of related biological or pharmaceutical treatments. Moreover, companion diagnostics also help medical personnel evaluate the benefits as well as risks of therapeutic treatments.
Drugs have been manufactured by pharmaceutical companies through the use of a ‘one size fits all’ approach. However, more than 50% of patients do not respond to some drugs, including cancer therapies. In this regard, personalized medicine is used. In the field of personalized medicine, decisions associated with an individual’s disease’s prevention, diagnosis, and treatment, are primarily guided by their genetic profile. Various molecular biomarkers depicting certain gene variants are also being discovered by virtue of genomic studies.
While the development of diagnostic tests has further encouraged the usage of these biomarkers, presently, it is more convenient to diagnose an illness with such testing methods. Therefore, the surging popularity of precision medicines plays a vital role in fueling the global companion diagnostics market growth.
REGIONAL INSIGHTS
The global companion diagnostics market growth assessment entails the in-depth study of North America, Europe, Asia-Pacific, and Rest of World. North America is set to capture the highest market share during the forecast period. The region’s notable growth is reinforced by the rising focus on democratizing precision medicine for various therapeutic applications and the surging prevalence of chronic diseases, such as diabetes as well as cardiovascular conditions.
COMPETITIVE INSIGHTS
As the global companion diagnostics market is highly emerging and poses escalating lucrative opportunities, the need for companion diagnostics observes robust growth. Furthermore, developing markets have recently acquired the attention of eminent players due to the significant potential present therein.
Some of the top players operating in the market are Arup Laboratories, Biomerieux, Abbott Laboratories, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

관련조사보고서

Inkwood Research에서는 아래의 지역/국가별 시장조사보고서도 출판되어 있습니다.각 보고서의 상세 설명에 대한 문의도 받고 있습니다。

  • ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET FORECAST 2022-2030
    아시아 태평양 지역의 컴패니언 진단 시장 예측 2022-2030년
  • EUROPE COMPANION DIAGNOSTICS MARKET FORECAST 2022-2030
    유럽 ​​컴패니언 진단 시장 예측 2022-2030년
  • NORTH AMERICA COMPANION DIAGNOSTICS MARKET FORECAST 2022-2030
    북미 컴패니언 진단 시장 예측 2022-2030년
  • INDIA COMPANION DIAGNOSTICS MARKET FORECAST 2022-2028
    인도 컴패니언 진단 시장 예측 2022-2028년

목차

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • GROWING NUMBER OF CANCER CASES AND MORTALITIES
      • INCREASING POPULARITY OF PRECISION MEDICINES
      • RISING NUMBER OF ADVERSE DRUG REACTION CASES
    • KEY RESTRAINTS
      • COUNTRY-SPECIFIC REIMBURSEMENT ISSUES
      • FREQUENT CASES OF LEAKAGE IN COMPANION DIAGNOSTICS FOR ONCOLOGY
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON COMPANION DIAGNOSTICS MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • REGULATORY FRAMEWORK
  2. MARKET BY TECHNOLOGY
    • IN SITU HYBRIDIZATION
    • POLYMERASE CHAIN REACTION
    • IMMUNOHISTOCHEMISTRY
    • NEXT GENERATION SEQUENCING
    • OTHER TECHNOLOGIES
  3. MARKET BY INDICATION
    • ONCOLOGY
    • NEUROLOGY
    • INFECTIOUS DISEASES
    • OTHER INDICATIONS
  4. MARKET BY END-USER
    • PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
    • REFERENCE LABORATORIES
    • OTHER END-USERS
  5. MARKET BY PRODUCTS & SERVICES
    • ASSAY KITS AND REAGENTS
    • SOFTWARE & SERVICES
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • SPAIN
        • ITALY
        • POLAND
        • NETHERLANDS
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • SINGAPORE
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
    • COMPANY PROFILES
      • ABBOTT LABORATORIES
      • AGILENT
      • ALAMC GROUP
      • ARUP LABORATORIES
      • BIOCARTIS
      • BIOMERIEUX SA
      • DANAHER CORPORATION
      • GE HEALTHCARE
      • GENOMIC HEALTH
      • ILLUMINA INC
      • MYRIAD GENETICS INC
      • QIAGEN NV
      • ROCHE DIAGNOSTICS
      • SYSMEX CORPORATION
      • THERMO FISHER SCIENTIFIC INC

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – COMPANION DIAGNOSTICS

TABLE 2: NEW CASES OF CANCER PATIENTS IN 2020

TABLE 3: GLOBAL COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 4: GLOBAL COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 5: GLOBAL IN SITU HYBRIDIZATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: GLOBAL IN SITU HYBRIDIZATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: GLOBAL POLYMERASE CHAIN REACTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: GLOBAL POLYMERASE CHAIN REACTION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: GLOBAL IMMUNOHISTOCHEMISTRY COMPANION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: GLOBAL IMMUNOHISTOCHEMISTRY COMPANION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: GLOBAL COMPANION DIAGNOSTICS MARKET, BY INDICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16: GLOBAL COMPANION DIAGNOSTICS MARKET, BY INDICATION FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19: GLOBAL NEUROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 20: GLOBAL NEUROLOGY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 21: GLOBAL INFECTIOUS DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 22: GLOBAL INFECTIOUS DISEASES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 23: GLOBAL OTHER INDICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 24: GLOBAL OTHER INDICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 25: GLOBAL COMPANION DIAGNOSTICS MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 26: GLOBAL COMPANION DIAGNOSTICS MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 27: GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 28: GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 29: GLOBAL REFERENCE LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 30: GLOBAL REFERENCE LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 31: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 32: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 33: GLOBAL COMPANION DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 34: GLOBAL COMPANION DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 35: GLOBAL ASSAY KITS AND REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 36: GLOBAL ASSAY KITS AND REAGENTS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 37: GLOBAL SOFTWARE & SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 38: GLOBAL SOFTWARE & SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 39: GLOBAL COMPANION DIAGNOSTICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 40: GLOBAL COMPANION DIAGNOSTICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 41: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 42: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 43: LEADING PLAYERS OPERATING IN NORTH AMERICA COMPANION DIAGNOSTICS MARKET

TABLE 44: EUROPE COMPANION DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 45: EUROPE COMPANION DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 46: LEADING PLAYERS OPERATING IN EUROPE COMPANION DIAGNOSTICS MARKET

TABLE 47: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 48: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 49: LEADING PLAYERS OPERATING IN ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET

TABLE 50: REST OF WORLD COMPANION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 51: REST OF WORLD COMPANION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 52: LEADING PLAYERS OPERATING IN REST OF WORLD COMPANION DIAGNOSTICS MARKET

TABLE 53: LIST OF MERGERS & ACQUISITIONS

TABLE 54: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 55: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES 

FIGURE 1: CDX LEAKAGE

FIGURE 2: KEY MARKET TRENDS

FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: VALUE CHAIN ANALYSIS

FIGURE 7: FDA GUIDELINES FOR CDX APPROVAL

FIGURE 8: GLOBAL COMPANION DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

FIGURE 9: GLOBAL COMPANION DIAGNOSTICS MARKET, BY IN SITU HYBRIDIZATION, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL COMPANION DIAGNOSTICS MARKET, BY POLYMERASE CHAIN REACTION, 2022-2030 (IN $ MILLION)

FIGURE 11: GLOBAL COMPANION DIAGNOSTICS MARKET, BY IMMUNOHISTOCHEMISTRY, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL COMPANION DIAGNOSTICS MARKET, BY NEXT GENERATION SEQUENCING, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL COMPANION DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL COMPANION DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY INDICATION, IN 2021

FIGURE 15: GLOBAL COMPANION DIAGNOSTICS MARKET, BY ONCOLOGY, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL COMPANION DIAGNOSTICS MARKET, BY NEUROLOGY, 2022-2030 (IN $ MILLION)

FIGURE 17: GLOBAL COMPANION DIAGNOSTICS MARKET, BY INFECTIOUS DISEASES, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL COMPANION DIAGNOSTICS MARKET, BY OTHER INDICATIONS, 2022-2030 (IN $ MILLION)

FIGURE 19: GLOBAL COMPANION DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

FIGURE 20: GLOBAL COMPANION DIAGNOSTICS MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)

FIGURE 21: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REFERENCE LABORATORIES, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL COMPANION DIAGNOSTICS MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL COMPANION DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY PRODUCTS & SERVICES, IN 2021

FIGURE 24: GLOBAL COMPANION DIAGNOSTICS MARKET, BY ASSAY KITS AND REAGENTS, 2022-2030 (IN $ MILLION)

FIGURE 25: GLOBAL COMPANION DIAGNOSTICS MARKET, BY SOFTWARE & SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 26: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 27: UNITED STATES COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 28: CANADA COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 29: EUROPE COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 30: UNITED KINGDOM COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 31: GERMANY COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 32: FRANCE COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 33: SPAIN COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 34: ITALY COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 35: POLAND COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 36: NETHERLANDS COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: REST OF EUROPE COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 38: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 39: CHINA COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: JAPAN COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 41: INDIA COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: SOUTH KOREA COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: INDONESIA COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 44: THAILAND COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: AUSTRALIA & NEW ZEALAND COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: REST OF ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: REST OF WORLD COMPANION DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 48: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)

FIGURE 49: MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)


    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com